This year there were two separate university outbreaks of Meningitis-B -- a strain of the illness that is not covered in U.S. vaccines.
Now, Novartis and Pfizer have each developed vaccines that protect against Meningitis-B.
They have been granted breakthrough therapy status by the FDA -- which could speed up the agency's consideration of the shots.
Earlier this year Princeton and UC Santa Barbara had Meningitis-B outbreaks.
Health officials brought in European vaccines to help stop the spread of Meningitis-B.